Page last updated: 2024-09-04

carbapenems and Cholangitis

carbapenems has been researched along with Cholangitis in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (14.29)	29.6817
2010's	3 (42.86)	24.3611
2020's	3 (42.86)	2.80

Authors

Authors	Studies
Armiñanzas-Castillo, C; Bahamonde-Carrasco, A; Boix-Palop, L; Cuquet-Pedragosa, J; Del Arco-Jiménez, A; Fernández-Natal, I; Fernandez-Suarez, J; Galan-Sanchez, F; Goikoetxea-Aguirre, AJ; Jóver-Saenz, A; León Jiménez, E; Lopez-Cortes, LE; López-Hernández, I; Martínez Pérez-Crespo, PM; Morán Rodríguez, MÁ; Mussa, M; Reguera-Iglesias, JM; Retamar-Gentil, P; Rodríguez-Baño, J; Sánchez-Calvo, JM; Sánchez-Porto, A; Smithson-Amat, A; Sousa-Dominguez, A; Vinuesa-García, D	1
Glaser, A; Jahangir, A; Mobarakai, N; Sahra, S; Sharif, MA	1
Jang, DK; Kim, J; Lee, JK; Park, WB; Yi, SY; Yoon, WJ	1
Igarashi, Y; Inui, K; Ohara, H; Ryozawa, S; Tazuma, S; Tsuyuguchi, T	1
Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Mezaki, K; Nagamatsu, M; Ohmagari, N; Takeshita, N; Tamura, S; Yamamoto, K	1
Chen, H; Chen, YG; Li, LJ; Li, YM; Praseedom, RK; Xie, HY; Zhang, Y; Zheng, SS; Zhou, L	1
Kato, K; Nishikawa, T; Sakai, Y; Sugiyama, H; Takahashi, M; Tsuyuguchi, T; Yokosuka, O	1

Trials

2 trial(s) available for carbapenems and Cholangitis

Article	Year
Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator. Journal of gastroenterology, 2015, Volume: 50, Issue:2 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Carbapenems; Cholangitis; Cholecystitis, Acute; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Young Adult	2015
Thymosin alpha1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria. The Journal of infectious diseases, 2008, Sep-01, Volume: 198, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Carbapenems; Cholangitis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Glycoproteins; Humans; Immunologic Factors; Intestinal Obstruction; Liver Abscess; Male; Middle Aged; Pancreatitis; Peritonitis; Sepsis; Thymalfasin; Thymosin	2008

Article

Year

Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator.

Journal of gastroenterology, 2015, Volume: 50, Issue:2

Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Carbapenems; Cholangitis; Cholecystitis, Acute; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Young Adult

2015

Thymosin alpha1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria.

The Journal of infectious diseases, 2008, Sep-01, Volume: 198, Issue:5

Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Carbapenems; Cholangitis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Glycoproteins; Humans; Immunologic Factors; Intestinal Obstruction; Liver Abscess; Male; Middle Aged; Pancreatitis; Peritonitis; Sepsis; Thymalfasin; Thymosin

2008

Other Studies

5 other study(ies) available for carbapenems and Cholangitis

Article	Year
Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project. Microbiology spectrum, 2022, 08-31, Volume: 10, Issue:4 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Biliary Tract; Carbapenems; Cholangiocarcinoma; Cholangitis; Cohort Studies; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Renal Insufficiency, Chronic; Risk Factors	2022
First case report of acute cholangitis secondary to Cronobacter sakazakii. BMC infectious diseases, 2021, May-27, Volume: 21, Issue:1 Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cholangitis; Cholecystostomy; Cronobacter sakazakii; Drainage; Enterobacteriaceae Infections; Humans; Male; Opportunistic Infections; Polymerase Chain Reaction; Tomography, X-Ray Computed; Treatment Outcome	2021
Increasing burden of biliary tract infection caused by extended-spectrum beta-lactamase-producing organisms in Korea: A nationwide population-based study. Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:1 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Cholangitis; Female; Humans; Male; Middle Aged; Republic of Korea; Time Factors	2020
Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis. Japanese journal of infectious diseases, 2017, Mar-24, Volume: 70, Issue:2 Topics: Aerobiosis; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Arthrobacter; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cholangitis; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Doripenem; Gram-Positive Bacterial Infections; Humans; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam	2017
Clinical usefulness of doripenem (DRPM), a carbapenem antimicrobial drug, for the treatment of patients with acute cholangitis: retrospective study. International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:1 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Carbapenems; Cholangitis; Doripenem; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2013